MAPT and Cognitive impairment: Moreover, the pharmacological inhibition of AEP using compound 11, the clearance of Tau N368 via antibody administration, and the application of a PPAR-δ agonist all demonstrated significant efficacy in alleviating the depressive-like behaviors and cognitive impairments induced by CRS in mice.